H.C. Wainwright reiterates Buy rating on Akari Therapeutics stock at $1.60

Related
One Liberty Properties declares $0.45 dividend
10 minutes ago
0
Cboe plans to launch futures and options on new Magnificent ...
12 minutes ago
0
Terreno Realty buys 3 industrial properties in Florida, New ...
21 minutes ago
0
AppLovin attracting short sellers' interest again - report
27 minutes ago
0
TD Cowen gives three reasons to bank on Nike's turnaround
28 minutes ago
0
How much does YouTube pay for 1,000 views in India? A comple...
28 minutes ago
0
Astronics shares jump after convertible note refinancing
29 minutes ago
0
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundat...
29 minutes ago
0
Mohamed El-Erian: Consumers can no longer absorb price incre...
29 minutes ago
0
Prachand Entertainment Emerges as India’s only production ho...
32 minutes ago
0
Netflix and Amazon tie up for programmatic ads partnership
35 minutes ago
0
GameStop rallies as it starts to look slightly more like a v...
35 minutes ago
0
Robinhood to roll out its own social platform in 'financial ...
35 minutes ago
0
Las Vegas mayor says the city is suffering from a serious dr...
42 minutes ago
0
Newmont upgraded at RBC on gold outlook, turnaround progress...
43 minutes ago
0
Crude inventory rises by 3.9M barrels for week ended Sept 5 ...
43 minutes ago
0
Veeva Systems partners with Gilead for Vault CRM
44 minutes ago
0
For OpenAI’s chief revenue officer, research chops rather th...
44 minutes ago
0
Jamie Dimon says economy is ‘weakening’ but he can’t make se...
46 minutes ago
0
Treasury yields drift down after surprise decline in August ...
48 minutes ago
0